Ikarian Capital »

Promis Neurosciences shares owned by Ikarian Capital

Quarter-by-quarter ownership of Promis Neurosciences (PMN) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Promis Neurosciences

Tip: Access up to 7 years of quarterly data

All positions including Promis Neurosciences held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Promis Neurosciences by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $699k 55k 12.70

More positions owned by Ikarian Capital

Terns Pharmaceuticals (TERN)
Spdr Series Trust State Street Spd Put Option (XBI)
Cytokinetics Com New (CYTK)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Kodiak Sciences (KOD)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Abivax Sa Sponsored Ads (ABVX)
Alumis (ALMS)
Bristol Myers Squibb Put Option (BMY)
Capricor Therapeutics Com New (CAPR)
Revolution Medicines (RVMD)
Vaxcyte (PCVX)
Praxis Precision Medicines I Com New (PRAX)
Biosante Pharmaceuticals (ANIP)
Harrow Health (HROW)

View all positions for Ikarian Capital

Top funds holding Promis Neurosciences

Henderson Group
Deep Track Capital
Trails Edge Capital Partners
Ally Bridge Group
Woodline Partners
Dr. Jeffrey R. Jay, M.D.
Yu Fan
Sphera Funds Management
Squadron Capital Management
ADAR1 Capital Management
683 Capital Management
Millennium Management
Empery Asset Management
Ikarian Capital
Boothbay Fund Management

View all funds holding Promis Neurosciences